VistaGen Therapeutics, Inc. (VTGN) Max Pain Analysis

Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.

VistaGen Therapeutics, Inc. (VTGN) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $21.5M, listed on NASDAQ, employing roughly 48 people, carrying a beta of 0.30 to the broader market. VistaGen Therapeutics, Inc. Led by Shawn K. Singh, public since 2011-06-21.

Snapshot as of May 15, 2026.

Spot Price
$0.62
Total OI
30.0K

Learn how max pain is reported and how to read the data →